Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Feb
16
2018
White House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices Epstein Becker & Green, P.C.
Aug
18
2021
Vaccine Mandates, Mandate Bans, Wage and Hour Nomination Stalls – Employment Law This Week [VIDEO] Epstein Becker & Green, P.C.
Nov
20
2018
FDA Loosens the Reins on Informed Consent Requirements for Certain Clinical Studies Epstein Becker & Green, P.C.
Jan
13
2022
CMS “Splits the Baby” on Aduhelm—Medicare Coverage but Only with Evidence Development for Now Epstein Becker & Green, P.C.
May
20
2022
Recent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products Epstein Becker & Green, P.C.
Feb
3
2015
Are Lower Cost Drugs Less Effective? It May Depend on the Patient’s Perspective. Epstein Becker & Green, P.C.
Feb
12
2015
Prescribing and Telemedicine: The “Physical” Exam Epstein Becker & Green, P.C.
Aug
14
2019
What’s New in E-Cigarette Regulation? Epstein Becker & Green, P.C.
Sep
13
2019
The FDA Looks Inward as It Tackles Interoperability Epstein Becker & Green, P.C.
Aug
28
2015
Health Resources and Service Administration (HRSA) Issues Proposed “Omnibus Guidance” Epstein Becker & Green, P.C.
Jan
31
2023
FDA Issues Final and Draft Guidance Documents Regarding Food Allergen Labeling Epstein Becker & Green, P.C.
Dec
14
2023
President Seeks More Antitrust Scrutiny of Health Care Transactions Epstein Becker & Green, P.C.
Nov
6
2020
Get Out the Toke: State Ballot Initiatives Legalize Marijuana and More Epstein Becker & Green, P.C.
Jan
22
2018
New State Laws Allow Telehealth Prescriptions for Controlled Substances; Yet, Regulatory Obstacles Still Remain Epstein Becker & Green, P.C.
Jun
4
2021
EEOC Updates Guidance on COVID-19 Vaccination Policies, Including Mandates, Incentives, and Accommodations Epstein Becker & Green, P.C.
Jul
11
2018
State Attorneys General Investigating Use of Non-Competes by Fast Food Franchisors Epstein Becker & Green, P.C.
Oct
19
2018
New Federal Laws Banning “Gag Clauses” in the Pharmacy Epstein Becker & Green, P.C.
Feb
16
2022
Employers Take Heed: Follow Illinois Biometric Privacy Rules or Risk a Losing Battle Epstein Becker & Green, P.C.
May
20
2022
The VALID Act: Senate Action Brings FDA Regulation of LDTs Closer to Fruition Epstein Becker & Green, P.C.
Jan
27
2015
Telemedicine has an Unlikely Ally: The Federal Trade Commission (FTC) Epstein Becker & Green, P.C.
Aug
24
2023
New York Cannabis Lawsuit Overview and Possible Effects on the Much-Anticipated Adult-Use Cannabis License Application Period Epstein Becker & Green, P.C.
Apr
3
2020
Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic Epstein Becker & Green, P.C.
Sep
28
2023
Diagnosing Health Care Podcast – Episode 70: Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs [Podcast] Epstein Becker & Green, P.C.
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Feb
6
2024
Unpacking Averages: Device Manufacturers Should Use the Newly Released Demographic Data in MDRs to Ensure Their Devices Are Not Disproportionately Hurting Minorities Epstein Becker & Green, P.C.
Mar
5
2024
SAMHSA Final Rule Regarding OTPs Expands Access, Increases Flexibility for Patients Epstein Becker & Green, P.C.
Apr
14
2022
Entrepreneurship in Biotech: Growing Your Business – Diagnosing Health Care [VIDEO] Epstein Becker & Green, P.C.
Jun
23
2022
CMS Reduces COVID-19 Vaccine Mandate Surveys and Rescinds Surveyor Vaccination Requirements Epstein Becker & Green, P.C.
Jun
4
2019
FDA Hosts Long-Awaited Cannabis Public Hearing Epstein Becker & Green, P.C.
Apr
14
2015
A Call to Comment for Telemedicine Stakeholders: The Cadillac Tax Epstein Becker & Green, P.C.
Aug
5
2019
Employment Law This Week®: Cannabis User Protections, WHD Opinion Letters, New Salary History Bans, NYS Anti-Harassment Training Deadline [VIDEO] Epstein Becker & Green, P.C.
Sep
25
2019
FDA Guidance Clarifies HDE Program Review Epstein Becker & Green, P.C.
Jul
13
2023
The 2023 DOJ Health Care Fraud Enforcement (f/k/a “Takedown”): Big Dollars or Clever Packaging? Epstein Becker & Green, P.C.
Mar
24
2020
FDA Confirms That At-Home Collection Kits Are Not Authorized for Use with COVID-19 Tests Epstein Becker & Green, P.C.
Mar
31
2020
HHS Issues Blanket Waivers for Certain Financial Relationships Subject to the Stark Law Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins